C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2006
12/12/2006	US7148356 Boriding aromatic compounds with (di)borane; reacting with ectrophilic compound containing halogen
12/12/2006	US7148304 Polymerization catalysts
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006	US7148244 Medicines in controlling Vpr function
12/12/2006	US7148243 N-((2-hydroxy,3-(alkyloxo),6-halophenyl)-(1,2-cyclopropylene) -),N'-((5-cyano or bromo)pyrid-2-yl)urea; retroviricides; HIV reverse transcriptase inhibitors; prolonged time to virus resistance
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148224 Pyrazinone derivatives
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148198 Antibacterial agents
12/12/2006	US7148174 Catalysts for olefin polymerization with transition metal compound
12/12/2006	US7148029 Generating antibodies; quantitative analysis
12/12/2006	CA2140106C Method of treating hyperproliferative vascular disease
12/07/2006	WO2006103342A3 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/07/2006	WO2006097817A9 N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
12/07/2006	WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
12/07/2006	WO2006053039A3 Hydroxybenzoate salts of metanicotine compounds
12/07/2006	WO2006014012A3 Aromatic compounds
12/07/2006	US20060276655 Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276517 Non-systemic control of parasites
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/06/2006	EP1727822A1 Novel compounds for modulating cell proliferation
12/06/2006	EP1727821A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1727801A1 Piperazines useful for treating pain
12/06/2006	EP1727800A1 Semicarbazide derivatives as kinase inhibitors
12/06/2006	EP1368319B1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/06/2006	EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006	EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same
12/06/2006	EP1079819B1 Hydroxamic acid derivatives as antibacterials
12/06/2006	CN1875026A Platinum complex and luminescent element
12/06/2006	CN1875015A Benzo [b][1,4] dioxepine derivatives
12/06/2006	CN1875002A Phenyl derivatives as PPAR agonists
12/06/2006	CN1875001A Benzannelated compounds as PPAR activators
12/06/2006	CN1875000A Method for producing bactericidal pyridine compound and bactericidal pyridine compound
12/06/2006	CN1288211C Pyridone dyes, a process for their preparation and their use in production of colorued plastics or polymeric colour particles
12/06/2006	CN1288153C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
12/06/2006	CN1287897C Preparation process of load type synthetic methyl pyrdine catalyst
12/05/2006	US7145039 Transfection reagents
12/05/2006	US7145035 Using palladium alkylation catalyst
12/05/2006	US7145015 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents
12/05/2006	US7144920 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
12/05/2006	US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2189652C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
12/03/2006	CA2547744A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
11/2006
11/30/2006	WO2006127205A2 Methods of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006125337A1 α, β- AND, Ϝ-UNSATURATED CARBOXYLATES AND THE USE AS HERBICIDIDE THEREOF
11/30/2006	WO2006061715A3 Methylene inhibitors of matrix metalloproteinase
11/30/2006	US20060270856 Process for preparation of sulfamide derivatives
11/30/2006	US20060270851 Production process of optically pure 2-(4- hydroxyphenoxy)-propionic acid compounds
11/30/2006	US20060270714 Novel n-substituted 2-aminopyridine derivatives
11/30/2006	US20060270693 Ether derivative
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	US20060269609 preparing 6-methyl-2-[4-(4-morpholino)anilino]nicotinic acid by reacting 2-chloro-6-methylnicotinic acid with 4-(4-morforino)aniline; effective for inhibiting the replication of hepatitis C virus
11/30/2006	US20060267488 electroluminescent thin films containing anthracene derivatives between anodes and cathodes, used as light emitters ahving efficiency and durability
11/30/2006	DE10218704B4 Halosulfonylbenzoesäurehalogenide, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von substituierten Phenylsulfonylharnstoffen Halosulfonylbenzoesäurehalogenide, processes for their preparation and their use for the preparation of substituted phenylsulfonylureas
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2608394A1 Methods of preparing 3-cyano-quinolines and intermediates made thereby
11/29/2006	EP1726594A1 Salts comprising cynoborate anions
11/29/2006	EP1726593A1 Salts comprising cyanoborate anions
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1725523A1 Ion channel modulators
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1146866B1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
11/29/2006	EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP0971854B1 Novel materials useful as electrolytic solutes
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers
11/29/2006	CN1871220A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
11/29/2006	CN1871219A Hexylcarboxanilide
11/29/2006	CN1871218A Isopentyl carboxanilides for combating undesired micro-organisms
11/29/2006	CN1871209A Insecticide for agricultural or horticultural use and method of use thereof
11/29/2006	CN1871208A Aralkyl amines as cannabinoid receptor modulators
11/29/2006	CN1871002A Alkynes II
11/29/2006	CN1871001A Alkynes III
11/29/2006	CN1870999A Alkynes I
11/29/2006	CN1869029A Process for the asymmetric epoxidation of olefins
11/29/2006	CN1869023A Synthesis of 2-methyl pyridine by acetylene acetonitrile method
11/29/2006	CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV)
11/29/2006	CN1286814C Separation and purification method of pyriproxyfen
11/29/2006	CN1286813C Cyanoacrylate compounds containing fluoro pyridine-methylamino group and their bioactivity
11/29/2006	CN1286801C Dielectric substance with block effect preventing copper diffusion
11/28/2006	US7141674 Anti-inflammatory compounds

1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 633